45 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

GENVEC Competitors or Alternatives

GENVEC's top competitors include Selecta, Spark Therapeutics and bluebird bio.

Unlock 37 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

GENVEC's company profile

Douglas J. Swirsky

President & CEO

67/100
25 - 100
$64M
$100K - 5M
  • $64M
    $100K - 5M
  • 25 - 100
    $64M
  • $100K - 5M
  • 67/100
  • 25 - 100
  • $64M
  • $100K - 5M
View ProfileView
1
GENVEC's Competitor - Selecta logo

CEO

- -
25 - 100
$555.8M
$25M - 100M
  • $555.8M
    $25M - 100M
  • 25 - 100
    $555.8M
  • $25M - 100M
  • - -
  • 25 - 100
  • $555.8M
  • $25M - 100M
View ProfileView
2
GENVEC's Competitor - Spark Therapeutics logo

Sylke Poehling

CEO

82/100
500 - 1,000
$886.2M
$25M - 100M
  • $886.2M
    $25M - 100M
  • 500 - 1,000
    $886.2M
  • $25M - 100M
  • 82/100
  • 500 - 1,000
  • $886.2M
  • $25M - 100M
View ProfileView
3
GENVEC's Competitor - bluebird bio logo

Andrew Obenshain

CEO

73/100
520
$821.4M
$103.9M
  • $821.4M
    $103.9M
  • 520
    $821.4M
  • $103.9M
  • 73/100
  • 520
  • $821.4M
  • $103.9M
View ProfileView
4
GENVEC's Competitor - Intellia Therapeutics logo

John Leonard

President & CEO

81/100
600
$883.6M
$57.5M
  • $883.6M
    $57.5M
  • 600
    $883.6M
  • $57.5M
  • 81/100
  • 600
  • $883.6M
  • $57.5M
View ProfileView
5
GENVEC's Competitor - Sangamo logo

Sandy Macrae

President & CEO

68/100
480
$71.5M
$32.9M
  • $71.5M
    $32.9M
  • 480
    $71.5M
  • $32.9M
  • 68/100
  • 480
  • $71.5M
  • $32.9M
View ProfileView
GENVEC's top 40 competitors are Selecta, Spark Therapeutics, bluebird bio, Alnylam, Intellia Therapeutics, Sangamo, CRISPR, Anokion, AnTolRx, TG Therapeutics, Homology, Amunix, Exagen, Apitope, Arrowhead, Gyroscope, Ra Pharma, Transgene, Senti Bio, Voyager, Regulus, Vineti, Emmaus, Editas Medicine, Genentech, Viela Bio, Elcelyx Therapeutics, Gelesis, Asklepios, Cyteir, Caribou, Recursion, Dimension Therapeutics, Blueprint, Intas, Sanofi Genzyme, Lysogene, Peloton Therapeutics, Axolabs and Merck. Together they have raised over 30.8B between their estimated 186.0K employees. GENVEC's revenue is the ranked 40th among it's top 10 competitors. The top 10 competitors average 2.6B. GENVEC has 30 employees and is ranked 36th among it's top 10 competitors. The top 10 competitors average 4,536.

GENVEC VS Selecta

Selecta has been one of GENVEC's top competitors. Selecta was founded in 2007, and is headquartered in Gaithersburg, Maryland. Selecta competes in the Biotechnology industry. Selecta generates $25.6M more revenue vs. GENVEC.

GENVEC VS Spark Therapeutics

Spark Therapeutics is a top competitor of GENVEC. Spark Therapeutics is a Private company that was founded in Philadelphia, Pennsylvania in 2011. Like GENVEC, Spark Therapeutics also competes in the Biotechnology industry. Spark Therapeutics has 770 more employees vs. GENVEC.

GENVEC VS bluebird bio

bluebird bio is perceived as one of GENVEC's biggest rivals. bluebird bio was founded in 1992, and its headquarters is in Somerville, Massachusetts. Like GENVEC, bluebird bio also operates in the Biotechnology field. bluebird bio has 490 more employees than GENVEC.

Looking for similar companies to GENVEC?

Similar Companies

Pharmaceuticals companies in Gaithersburg

See 16 companies 
Pharmaceuticals companies in Maryland

See 174 companies 
Pharmaceuticals & Biotechnology companies in Gaithersburg

See 61 companies 
Biotechnology companies in Gaithersburg

See 48 companies 
Pharmaceuticals companies in Washington Metropolitan Area

See 184 companies 
Companies in Gaithersburg with revenue in $100K-5.0M range

See 347 companies 
Biotechnology companies in Washington Metropolitan Area

See 352 companies 
Biotechnology companies in Maryland

See 395 companies 
Pharmaceuticals & Biotechnology companies in Washington Metropolitan Area

See 496 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for GENVEC and GENVEC's Competitors

January 12, 2026Nasdaq
(RTTNews) - Alnylam Pharmaceuticals, Inc. (ALNY) announced its new five-year strategy, "Alnylam 2030." The plan is designed to scale the company's oper...
January 12, 2026Nasdaq
Key PointsThe president and CEO of Intellia Therapeutics sold 34,146 directly held shares of the firm on Jan. 5....
January 12, 2026Seeking Alpha
January 11, 2026Yahoo
Exagen Inc. CARLSBAD, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced se...
January 12, 2026GlobalNewswire
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of December 31, 2025...
January 12, 2026Nasdaq
In trading on Monday, shares of Alnylam Pharmaceuticals Inc (Symbol: ALNY) crossed below their 200 day moving average of $375.22, changing hands as low...
January 12, 2026centralcharts
-2026 is poised to be a data- and milestone-rich year across the portfolio- -CASGEVY ® launch acceleration continues, supporting multi-billion-dollar...
January 12, 2026Benzinga
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) announced a new five-year roadmap, "Alnylam 2030," on Sunday, outlining the company's focus on scaling its o...

Frequently Asked Questions about GENVEC

  1. Who are GENVEC's top competitors?

    GENVEC's top 3 competitors are Selecta, Spark Therapeutics, bluebird bio.

  2. Who is similar to GENVEC?

    Selecta is the most similar to GENVEC. Spark Therapeutics and bluebird bio are also similar to GENVEC.

  1. Are GENVEC and Selecta competitors?

    Yes, Selecta is one of GENVEC’s top competitors.